Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Ratcliffe Liam
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-12-14
Sale
2021-12-16
9:30 pm
ARVINAS Inc ARVN Ratcliffe Liam
Director
355,705 $67 $23,833,381 185,686
(Indirect)
View
2021-11-10
Sale
2021-11-15
9:45 pm
ARVINAS Inc ARVN Ratcliffe Liam
Director
134,310 $85.83 $11,527,510 541,391
(Indirect)
View
2021-11-05
Sale
2021-11-09
9:47 pm
ARVINAS Inc ARVN Ratcliffe Liam
Director
172,079 $93.02 $16,006,424 675,701
(Indirect
Direct)
View
2020-12-18
Purchase
2020-12-21
6:00 pm
ARVINAS Inc ARVN Ratcliffe Liam
Director
142,857 $70 $9,999,990 822,857
(Indirect)
View
2020-03-03
Purchase(A)
2020-03-13
5:20 pm
Passage BIO Inc. PASG Ratcliffe Liam
Director
552,800 $18 $9,950,400 2,619,430
(Indirect
Direct)
View
2020-03-03
Purchase
2020-03-03
6:48 pm
Passage BIO Inc. PASG Ratcliffe Liam
Director
2,800 $18 $50,400 2,800
(Direct)
View
2019-11-12
Purchase
2019-11-14
4:23 pm
ARVINAS Inc ARVN Ratcliffe Liam
Director
680,000 $22 $14,960,000 680,000
(Indirect)
View
2018-10-01
Purchase
2018-10-03
5:22 pm
ARVINAS Inc ARVN Ratcliffe Liam
Director
1,000,000 $16 $16,000,000 375,000
(Indirect)
View
2018-06-25
Purchase
2018-06-26
4:53 pm
Aptinyx Inc. APTX Ratcliffe Liam
Director
10% Owner
250,000 $16 $4,000,000 368,345
(Indirect)
View
2018-05-30
Purchase
2018-05-31
4:54 pm
Iterum Therapeutics plc ITRM Lathi Vijay K
Ratcliffe Liam
10% Owner
662,677 $13 $8,614,801 384,615
(Indirect)
View
2018-04-03
Purchase
2018-04-03
4:30 pm
Unum Therapeutics Inc. UMRX Ratcliffe Liam
Director
550,000 $12 $6,600,000 897,773
(Indirect)
View
2017-10-02
Purchase
2017-10-02
4:40 pm
Deciphera Pharmaceuticals Inc. DCPH Ratcliffe Liam
Director
10% Owner
375,000 $17 $6,375,000 2,146,308
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-16
Option Award
2022-06-21
8:00 pm
N/A
2032-06-15
ARVINAS Inc ARVN Ratcliffe Liam
Director
10,192 $0 10,192
(Direct)
View
2022-05-19
Option Award
2022-06-01
5:14 pm
N/A
2032-05-18
Eliem Therapeutics Inc. ELYM Ratcliffe Liam
Director
10,000 $0 10,000
(Direct)
View
2021-11-05
Exercise
2021-11-09
9:47 pm
N/A
N/A
ARVINAS Inc ARVN Ratcliffe Liam
Director
12,000 $33.57 675,701
(Direct)
View
2021-11-05
Exercise
2021-11-09
9:47 pm
N/A
N/A
ARVINAS Inc ARVN Ratcliffe Liam
Director
6,423 $22.06 675,701
(Direct)
View
2021-11-05
Exercise
2021-11-09
9:47 pm
N/A
2029-05-22
ARVINAS Inc ARVN Ratcliffe Liam
Director
18,423 $0 675,701
(Direct)
View
2021-08-09
Option Award
2021-08-11
5:23 pm
N/A
2031-08-08
Eliem Therapeutics Inc. ELYM Ratcliffe Liam
Director
20,000 $0 20,000
(Direct)
View
2021-08-09
Ownership
2021-08-09
6:22 pm
N/A
N/A
Eliem Therapeutics Inc. ELYM Ratcliffe Liam
Director
0 $0 0
(Direct)
View
2021-06-08
Option Award
2021-06-10
8:00 pm
N/A
2021-06-07
ARVINAS Inc ARVN Ratcliffe Liam
Director
7,511 $0 7,511
(Direct)
View
2021-05-27
Option Award
2021-05-28
5:58 pm
N/A
2031-05-26
Passage BIO Inc. PASG Ratcliffe Liam
Director
16,918 $0 16,918
(Direct)
View
2020-06-03
Option Award
2020-06-04
9:00 pm
N/A
2030-06-02
ARVINAS Inc ARVN Ratcliffe Liam
Director
12,000 $0 12,000
(Direct)
View
2020-05-26
Exercise
2020-05-27
6:34 pm
N/A
N/A
ARVINAS Inc ARVN Ratcliffe Liam
Director
6,500 $22.06 692,923
(Direct)
View
2020-05-26
Exercise
2020-05-27
6:34 pm
N/A
2029-05-22
ARVINAS Inc ARVN Ratcliffe Liam
Director
6,500 $0 692,923
(Direct)
View
2020-03-03(A)
Conversion
2020-03-13
5:20 pm
N/A
N/A
Passage BIO Inc. PASG Ratcliffe Liam
Director
2,066,630 $0 2,619,430
(Indirect)
View
2020-02-27(A)
Ownership
2020-03-12
7:02 pm
N/A
N/A
Passage BIO Inc. PASG Ratcliffe Liam
Director
0 $0 2,066,630
(Indirect)
View
2020-02-27
Option Award
2020-03-02
5:58 pm
N/A
2030-02-27
Passage BIO Inc. PASG Ratcliffe Liam
Director
33,836 $0 33,836
(Direct)
View
2019-06-14
Option Award
2019-06-18
4:27 pm
N/A
2029-06-14
Unum Therapeutics Inc. UMRX Ratcliffe Liam
Director
7,881 $1.6654 7,881
(Direct)
View
2019-05-23
Option Award
2019-05-28
5:11 pm
N/A
2029-05-22
ARVINAS Inc ARVN Ratcliffe Liam
Director
12,923 $0 12,923
(Direct)
View
2019-04-01
Option Award
2019-04-03
4:32 pm
N/A
2029-04-01
Unum Therapeutics Inc. UMRX Ratcliffe Liam
Director
4,829 $2.7185 4,829
(Direct)
View
2019-03-29
Option Award
2019-04-02
4:24 pm
N/A
2029-03-28
Aptinyx Inc. APTX Ratcliffe Liam
Director
4,123 $2.425 4,123
(Direct)
View
2019-03-15
Exercise
2019-03-18
5:52 pm
N/A
N/A
Edge Therapeutics Inc. EDGE Ratcliffe Liam
Director
10,000 $0 2,354,868
(Direct)
View
2019-01-02
Option Award
2019-01-04
4:57 pm
N/A
2029-01-02
Unum Therapeutics Inc. UMRX Ratcliffe Liam
Director
4,860 $2.7 4,860
(Direct)
View
2018-10-01
Conversion
2018-10-03
5:22 pm
N/A
N/A
ARVINAS Inc ARVN Ratcliffe Liam
Director
5,452,957 $0 375,000
(Indirect)
View
2018-10-01
Option Award
2018-10-03
5:19 pm
N/A
2028-10-01
Unum Therapeutics Inc. UMRX Ratcliffe Liam
Director
2,111 $6.22 2,111
(Direct)
View
2018-09-26
Ownership
2018-09-26
8:53 pm
N/A
N/A
ARVINAS HOLDING COMPANY LLC ARVN Ratcliffe Liam
Director
10% Owner
0 $0 1,283,048
(Indirect)
View
2018-07-26
Option Award
2018-09-26
6:47 pm
N/A
2028-07-26
Unum Therapeutics Inc. UMRX Ratcliffe Liam
Director
1,504 $8.72 1,504
(Direct)
View
2018-08-14
Option Award
2018-08-15
08:05 am
N/A
N/A
Edge Therapeutics Inc. EDGE Ratcliffe Liam
Director
10,000 $0 10,000
(Direct)
View
2018-06-25
Conversion
2018-06-26
4:53 pm
N/A
N/A
Aptinyx Inc. APTX Ratcliffe Liam
Director
10% Owner
86,904,354 $0 368,345
(Indirect)
View
2018-06-20
Ownership
2018-06-20
7:41 pm
N/A
N/A
Aptinyx Inc. APTX Ratcliffe Liam
Director
10% Owner
0 $0 3,040,079
(Indirect)
View
2018-06-19
Option Award
2018-06-20
4:54 pm
N/A
N/A
Edge Therapeutics Inc. EDGE Ratcliffe Liam
Director
20,000 $0 20,000
(Direct)
View
2018-05-30
Conversion
2018-05-31
4:54 pm
N/A
N/A
Iterum Therapeutics plc ITRM Lathi Vijay K
Ratcliffe Liam
10% Owner
793,626 $0 384,615
(Indirect)
View
2018-05-24
Ownership
2018-05-24
6:38 pm
N/A
N/A
Iterum Therapeutics plc ITRM New Leaf Venture Management III L.L.C.
New Leaf Venture Associates III L.P.
New Leaf Ventures III L.P.
Lathi Vijay K
Ratcliffe Liam
10% Owner
0 $0 793,626
(Indirect)
View
2018-05-17
Option Award
2018-05-21
4:25 pm
N/A
2028-05-16
Deciphera Pharmaceuticals Inc. DCPH Ratcliffe Liam
Director
10% Owner
12,000 $0 12,000
(Direct)
View
2018-04-03
Conversion
2018-04-03
4:30 pm
N/A
N/A
Unum Therapeutics Inc. UMRX Ratcliffe Liam
Director
3,201,216 $0 897,773
(Indirect)
View
2018-03-28
Ownership
2018-03-28
8:58 pm
N/A
N/A
Unum Therapeutics Inc. UMRX Ratcliffe Liam
Director
0 $0 1,245,545
(Indirect)
View
2017-10-02
Conversion
2017-10-02
4:40 pm
N/A
N/A
Deciphera Pharmaceuticals Inc. DCPH Ratcliffe Liam
Director
10% Owner
3,270,443 $0 2,146,308
(Indirect)
View
(A) Indicate amendment filing.